Risk factors and epidemiology of human T-lymphotropic virus types 1 and 2 in US blood donors

Similar Items

• Risk Factors for Retrovirus and Hepatitis Virus Infections in Accepted Blood Donors
  od: Custer, Brian, i dr.
  Izdano: (2014)
• Cancer Incidence and Mortality in a Cohort of US Blood Donors: A 20-Year Study
  od: Vahidnia, Farnaz, i dr.
  Izdano: (2013)
• Erratum to “Cancer Incidence and Mortality in a Cohort of US Blood Donors: A 20-Year Study”
  od: Vahidnia, Farnaz, i dr.
  Izdano: (2014)
• Use of a rapid electronic survey methodology to estimate blood donors' potential exposure to emerging infectious diseases: Application of a statistically representative sampling methodology to assess risk in US blood centers
  od: Whitaker, Barbee I., i dr.
  Izdano: (2020)
• Change in Donor Characteristics and Antibodies to SARS-CoV-2 in Donated Blood in the US, June-August 2020
  od: Dodd, Roger Y., i dr.
  Izdano: (2020)